213 related articles for article (PubMed ID: 29870915)
21. Therapeutic applications of nucleic acids as ligands for Toll-like receptors.
Panter G; Kuznik A; Jerala R
Curr Opin Mol Ther; 2009 Apr; 11(2):133-45. PubMed ID: 19330719
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic applications of synthetic CpG oligodeoxynucleotides as TLR9 agonists for immune modulation.
Jurk M; Vollmer J
BioDrugs; 2007; 21(6):387-401. PubMed ID: 18020622
[TBL] [Abstract][Full Text] [Related]
23. Toward Establishing an Ideal Adjuvant for Non-Inflammatory Immune Enhancement.
Seya T; Tatematsu M; Matsumoto M
Cells; 2022 Dec; 11(24):. PubMed ID: 36552770
[TBL] [Abstract][Full Text] [Related]
24. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
Front Immunol; 2019; 10():179. PubMed ID: 30800129
[TBL] [Abstract][Full Text] [Related]
25. Cytosolic Nucleic Acid Sensors in Inflammatory and Autoimmune Disorders.
Khan S; Godfrey V; Zaki MH
Int Rev Cell Mol Biol; 2019; 344():215-253. PubMed ID: 30798989
[TBL] [Abstract][Full Text] [Related]
26. Structural insights into ligand recognition and regulation of nucleic acid-sensing Toll-like receptors.
Shimizu T
Curr Opin Struct Biol; 2017 Dec; 47():52-59. PubMed ID: 28600980
[TBL] [Abstract][Full Text] [Related]
27. Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors.
Romagne F
Drug Discov Today; 2007 Jan; 12(1-2):80-7. PubMed ID: 17198976
[TBL] [Abstract][Full Text] [Related]
28. Applications of chemokines as adjuvants for vaccine immunotherapy.
Mohan T; Zhu W; Wang Y; Wang BZ
Immunobiology; 2018; 223(6-7):477-485. PubMed ID: 29246401
[TBL] [Abstract][Full Text] [Related]
29. The path forward.
De Gregorio E
Vaccine; 2015 Jun; 33 Suppl 2():B60-3. PubMed ID: 26022572
[TBL] [Abstract][Full Text] [Related]
30. Pattern Recognition Receptors and Control of Innate Immunity: Role of Nucleic Acids.
Fischer S
Curr Pharm Biotechnol; 2018; 19(15):1203-1209. PubMed ID: 30636600
[TBL] [Abstract][Full Text] [Related]
31. Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides.
Krieg AM
Curr Oncol Rep; 2004 Mar; 6(2):88-95. PubMed ID: 14751085
[TBL] [Abstract][Full Text] [Related]
32. Understanding nucleic acid sensing and its therapeutic applications.
Kong LZ; Kim SM; Wang C; Lee SY; Oh SC; Lee S; Jo S; Kim TD
Exp Mol Med; 2023 Nov; 55(11):2320-2331. PubMed ID: 37945923
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA.
McCluskie MJ; Krieg AM
Curr Top Microbiol Immunol; 2006; 311():155-78. PubMed ID: 17048708
[TBL] [Abstract][Full Text] [Related]
34. Nucleic acid sensing Toll-like receptors in dendritic cells.
Hoshino K; Kaisho T
Curr Opin Immunol; 2008 Aug; 20(4):408-13. PubMed ID: 18585458
[TBL] [Abstract][Full Text] [Related]
35. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
Andersen JM; Al-Khairy D; Ingalls RR
Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
[TBL] [Abstract][Full Text] [Related]
36. Update on toll-like receptor-directed therapies for human disease.
Tse K; Horner AA
Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii77-80. PubMed ID: 17934102
[TBL] [Abstract][Full Text] [Related]
37. [The concept of immunocorrection in multifactor immunodeficiency states, infectious and cancerous diseases].
Kuznetsov VP; Beliaev DL; Babaiants AA
Zh Mikrobiol Epidemiol Immunobiol; 1996; (5):104-10. PubMed ID: 9082712
[No Abstract] [Full Text] [Related]
38. Nucleic acid-sensing Toll-like receptors: beyond ligand search.
Miyake K
Adv Drug Deliv Rev; 2008 Apr; 60(7):782-5. PubMed ID: 18321608
[TBL] [Abstract][Full Text] [Related]
39. Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes.
Zaks K; Jordan M; Guth A; Sellins K; Kedl R; Izzo A; Bosio C; Dow S
J Immunol; 2006 Jun; 176(12):7335-45. PubMed ID: 16751377
[TBL] [Abstract][Full Text] [Related]
40. Nucleic acids presenting polymer nanomaterials as vaccine adjuvants.
Comberlato A; Paloja K; Bastings MMC
J Mater Chem B; 2019 Nov; 7(41):6321-6346. PubMed ID: 31460563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
